Since its discovery in 1989, many studies have been conducted to define the biological role of tumor-derived CCL2 and the mechanisms regulating CCL2 production during the development and progression of BC both in vitro and in vivo (Fig. 6). The gene discussed is CCL2; the disease is breast cancer.